LONDON, 09 February 2026 – We are pleased to announce the appointment of Alain Reinhardt as Risk Control Consulting Director for Technology and Life Science.
Alain brings over 25 years’ industry experience to CNA Hardy, most recently serving as Senior Director of Risk at AstraZeneca. His extensive technical expertise and deep operational understanding will further enhance our broader Life Science and Technology specialisms, strengthening our ability to support clients in these highly specialised and fast evolving sectors.
Stuart Kenyon, AVP, Risk Control, said of the appointment: “Alain’s 25 years in industry bring not only deep technical knowledge but also a broader contextual understanding that elevates our collective expertise. His experience sharpens our insight and deepens our ability to anticipate and respond to client needs”.
“Alain’s appointment reinforces our commitment to providing expertly informed, forward looking solutions that meet the evolving needs of our Technology and Life Science clients.”